Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2016-05-22 03:37:26 UTC |
---|
Update Date | 2016-11-09 01:15:26 UTC |
---|
Accession Number | CHEM016574 |
---|
Identification |
---|
Common Name | 6-Azaribine |
---|
Class | Small Molecule |
---|
Description | A N-glycosyl-1,2,4-triazine that is 6-azauridine acetylated at positions 2', 3' and 5' on the sugar ring. It is a prodrug for 6-azauridine and is used for treatment of psoriasis. |
---|
Contaminant Sources | - ToxCast & Tox21 Chemicals
|
---|
Contaminant Type | Not Available |
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
2',3',5'-Tri-O-acetyl-6-azauridine | ChEBI | 2',3',5'-Triacetyl-6-azauridine | ChEBI | 2-(2',3',5'-Triacetyl-beta-D-ribofuranosyl)-as-triazine-3,5-(2H,4H)-dione | ChEBI | 2-beta-D-Ribofuranosyl-as-triazine-3,5(2H,4H)-dione 2',3',5'-triacetate | ChEBI | 6-Azauridine 2',3',5'-triacetate | ChEBI | Azaribina | ChEBI | Azaribinum | ChEBI | Triacetyl-6-azauridine | ChEBI | Triazure | ChEBI | 2-(2',3',5'-Triacetyl-b-D-ribofuranosyl)-as-triazine-3,5-(2H,4H)-dione | Generator | 2-(2',3',5'-Triacetyl-β-D-ribofuranosyl)-as-triazine-3,5-(2H,4H)-dione | Generator | 2-b-D-Ribofuranosyl-as-triazine-3,5(2H,4H)-dione 2',3',5'-triacetate | Generator | 2-b-D-Ribofuranosyl-as-triazine-3,5(2H,4H)-dione 2',3',5'-triacetic acid | Generator | 2-beta-D-Ribofuranosyl-as-triazine-3,5(2H,4H)-dione 2',3',5'-triacetic acid | Generator | 2-Β-D-ribofuranosyl-as-triazine-3,5(2H,4H)-dione 2',3',5'-triacetate | Generator | 2-Β-D-ribofuranosyl-as-triazine-3,5(2H,4H)-dione 2',3',5'-triacetic acid | Generator | 6-Azauridine 2',3',5'-triacetic acid | Generator | 6-Azauridine triacetate | MeSH | Triacetyl azauridine | MeSH |
|
---|
Chemical Formula | C14H17N3O9 |
---|
Average Molecular Mass | 371.302 g/mol |
---|
Monoisotopic Mass | 371.096 g/mol |
---|
CAS Registry Number | 2169-64-4 |
---|
IUPAC Name | [(2R,3R,4R,5R)-3,4-bis(acetyloxy)-5-(5-hydroxy-3-oxo-2,3-dihydro-1,2,4-triazin-2-yl)oxolan-2-yl]methyl acetate |
---|
Traditional Name | azaribine |
---|
SMILES | [H][C@]1(COC(C)=O)O[C@@]([H])(N2N=CC(O)=NC2=O)[C@]([H])(OC(C)=O)[C@]1([H])OC(C)=O |
---|
InChI Identifier | InChI=1S/C14H17N3O9/c1-6(18)23-5-9-11(24-7(2)19)12(25-8(3)20)13(26-9)17-14(22)16-10(21)4-15-17/h4,9,11-13H,5H2,1-3H3,(H,16,21,22)/t9-,11-,12-,13-/m1/s1 |
---|
InChI Key | QQOBRRFOVWGIMD-OJAKKHQRSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Carbohydrates and carbohydrate conjugates |
---|
Direct Parent | Glycosylamines |
---|
Alternative Parents | |
---|
Substituents | - N-glycosyl compound
- Tricarboxylic acid or derivatives
- Monosaccharide
- Triazine
- 1,2,4-triazine
- Tetrahydrofuran
- Heteroaromatic compound
- Lactam
- Carboxylic acid ester
- Organoheterocyclic compound
- Carboxylic acid derivative
- Azacycle
- Oxacycle
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organonitrogen compound
- Organopnictogen compound
- Organic nitrogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Not Available |
---|
Cellular Locations | Not Available |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Appearance | Not Available |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | Not Available | Solubility | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03k9-6659000000-b42ec6b468accd7fc8b0 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03di-2911000000-aea0317f696c3874ff21 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-03k9-9370000000-8dd461c9bc23f7c70f97 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0006-9101000000-beba90f37273cce226a1 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0296-9300000000-b649b657253ddaee5287 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0296-9200000000-6279e09f2a539d26f27d | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Not Available |
---|
Mechanism of Toxicity | Not Available |
---|
Metabolism | Not Available |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | Not Available |
---|
Uses/Sources | Not Available |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | Not Available |
---|
Treatment | Not Available |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
HMDB ID | Not Available |
---|
FooDB ID | Not Available |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
BiGG ID | Not Available |
---|
BioCyc ID | Not Available |
---|
METLIN ID | Not Available |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
Chemspider ID | Not Available |
---|
ChEBI ID | 88272 |
---|
PubChem Compound ID | 16574 |
---|
Kegg Compound ID | Not Available |
---|
YMDB ID | Not Available |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | |
---|